Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL764P is a human gene segment classified as a pseudogene; it resembles the coding sequence of the functional 7SL RNA gene, which is a core component of the signal recognition particle (SRP) involved in protein targeting to the endoplasmic reticulum. Unlike functional 7SL RNA, this pseudogene is not transcribed into a functional product and does not participate in protein synthesis or cellular signaling. Most 7SL-related pseudogenes are considered nonfunctional genomic fossils, resulting from reverse transcription events that reintegrate RNA sequences into the genome. Although rare pseudogene transcripts can play regulatory roles, no specific function, disease association, or drug interaction is described for RN7SL764P. Pseudogenes like RN7SL764P can complicate genetic analyses due to sequence similarity with functional genes.
null (no drugs reported; mechanism of action not applicable)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 764, pseudogene (RN7SL764P).